Key result
Early post-TAVI complications evaluated for link to 1-year quality of life outcomes.
Why the study?
Do early clinical complications impact 1-year SF-12-derived quality of life outcomes following TAVI?
Cohort
Do early clinical complications impact 1-year SF-12-derived quality of life outcomes following TAVI?
Clinical trial sub-study examines 1-year quality of life following transcatheter aortic valve implantation, highlighting how early complications shape long-term recovery.
The Valve Academic Research Consortium (VARC)-3 recommends the 12-item Short Form survey (SF-12) to assess quality of life (QoL) after transcatheter aortic valve implantation (TAVI). Although SF-12 outcomes after TAVI have been previously reported, most studies have focused primarily on pre- and post-procedural improvements. The association between clinical complications and post-TAVI QoL outcomes remains unexplored. This LANDMARK sub-study investigates the impact of early clinical complications on 1-year SF-12–derived QoL outcomes following TAVI.
No takes yet. Share an insight, caveat, or question.
Royen et al. (2026) conducted a cohort in Transcatheter aortic valve implantation (TAVI). Early clinical complications was evaluated on 1-year SF-12-derived quality of life outcomes.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: